カリフォルニア州における膀胱癌の臨床試験
カリフォルニア州内の拠点で、膀胱癌に関する54件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles24件の研究
- Baldwin Park14件の研究
- San Francisco13件の研究
- Orange12件の研究
- San Diego11件の研究
- Irvine11件の研究
- Sacramento10件の研究
- Torrance7件の研究
- Bakersfield7件の研究
- Santa Monica7件の研究
- Mountain View5件の研究
- Newport Beach4件の研究
- Long Beach3件の研究
- Santa Rosa3件の研究
- Alhambra3件の研究
- Santa Barbara3件の研究
- Santa Maria3件の研究
- Burbank3件の研究
公式研究テキスト（英語）
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- City of Hope National Medical Center, Duarte
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- UCSF Medical Center at Mission Bay ( Site 5044), San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07232602Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- 他20件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Los Angeles General Medical Center, Los Angeles
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06770582A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Michael G Oefelein Clinical Trials ( Site 0138), Bakersfield
- USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
- Genesis Healthcare-Torrance ( Site 0140), Torrance
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06833073A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- Ronald Reagan UCLA Medical Center, Los Angeles
- 他3件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
- University of California, San Francisco, San Francisco
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07664397Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Tower Cancer Research Foundation, Beverly Hills
- City of Hope Corona, Corona
- City of Hope Comprehensive Cancer Center, Duarte
- 他9件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07061964Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
- University of California, San Francisco, San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06470282Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- UCLA Hematology/Oncology - Alhambra, Alhambra
- UCLA Hematology/Oncology - Atascadero, Atascadero
- UCLA Hematology/Oncology - Beverly Hills, Beverly Hills
- 他39件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Duarte, Duarte
- Providence Medical Foundation, Santa Rosa
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- City of Hope, Duarte
- USC/Norris Comprehensive Cancer Center, Los Angeles
- UCSF Medical center Parnassus, San Francisco
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07217171ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of California, San Diego, La Jolla
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Redwood City, Redwood City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Michael G Oefelein Clinical Trials ( Site 0005), Bakersfield
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT07222488Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Michael G Oefelein, MD Clinical Trials, Bakersfield
- City of Hope, Irvine
- Genesis Research (Greater Los Angeles), Los Alamitos
- 他6件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06567743The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Michael Oefelein Clinical Trials, Bakersfield
- University of California Irvine Medical Center, Orange
- Genesis Research LLC, Torrance
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Michael Oefelein Clinical Trials, Bakersfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/21更新 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- City of Hope, Duarte
- University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
- University of California - Irvine, Orange
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739Patient-Derived Xenografts to Reduce Cancer Health Disparities
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
- University of California Davis Comprehensive Cancer Center, Sacramento
被験者募集中観察研究
21歳〜100歳 · 全性別 · 2026/08/20更新 · NCT04410302Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Los Angeles
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07129993Measuring Surgical Recovery After Radical Cystectomy
- Stanford University, Stanford
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT03193970Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07097142A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- University of California - Irvine Medical Center, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- USC/Norris Comprehensive Cancer Center, Los Angeles
- 他2件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Local Institution - 0162, Fullerton
- Palo Alto Center-Palo Alto Medical Foundation Research Institute, Palo Alto
- Sutter Health - Sutter Institute for Medical Research, Sacramento
- 他3件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/07/29更新 · NCT07106762A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, San Francisco
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/22更新 · NCT07720284A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Kaiser Permanente Anaheim Kraemer Medical Offices, Anaheim
- Foothill Cardioology, Arcadia
- Kaiser Permanente Baldwin Park Medical Center, Baldwin Park
- 他58件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/22更新 · NCT04879329Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/14更新 · NCT06580002A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07337525A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Providence Medical Foundation, Anaheim
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center Virginia K Crosson and Infusion Center, Fullerton
- 他7件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Predicting BCG Response
- Cedars-Sinai Medical Center, Los Angeles
- UCLA, Los Angeles
- UCSF, San Francisco
被験者募集中観察研究
18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT04564781ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。